Lirimilast is a small molecule drug. The usage of the INN stem '-milast' in the name indicates that Lirimilast is a Phosphodiesterase-4 (PDE4) inhibitor. Lirimilast has a monoisotopic molecular weight of 441.98 Da.
BAY 19-80043-(carbamoylamino)-2-(2,4-dichlorobenzoyl)-1-benzofuran-6-yl methanesulfonate[3-(carbamoylamino)-2-(2,4-dichlorobenzoyl)-1-benzofuran-6-yl] methanesulfonateEX-A5382BAY19-8004NCGC00263118-01MS-27976SMR004703312